To this end we employed RT-qPCR analysis, western blot and/or immunofluorescence to assess the expression of CD44, NANOG, OCT4 and SOX2, regarded as putative ovarian cancer stem cells markers [51, 52]. The gene discussed is NANOG; the disease is ovarian cancer.